anti-FcRn

Immunovant stakes claim for FcRn niche, posting midphase Graves’ data and plotting next steps
Fierce Biotech
Thu, 12/21/23 - 09:46 am
Immunovant
anti-FcRn
clinical trials
Graves' disease
Roivant
UCB chases after Argenx with FcRN drug for myasthenia gravis
Pharmaforum
Mon, 12/13/21 - 10:48 am
UCB Pharma
anti-FcRn
myasthenia gravis
rozanolixizumab
One less rival for Immunovant, as Alexion abandons FcRn inhibitor
Endpoints
Wed, 02/26/20 - 10:36 am
Alexion
anti-FcRn
Immunovant